Envisioning clinical trials as complex interventions.

Journal Information

Full Title: Cancer

Abbreviation: Cancer

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST Laura J. Damschroder reports a grant (paid to her institution) from the VA Quality Enhancement Research Initiative Program (QUE 20–025); payments as an expert implementation science consultant on National Institutes of Health‐funded projects; honoraria from Dartmouth College, Intermountain Healthcare, New York University, Oregon Health Sciences University, University of Illinois, University of Chicago, University of Michigan, University of Zurich, Upstream USA Inc, Yale University, McGill University, Agenica de Qualitat I Avaluacio Sanitaries de Catalunya, Brown University, Karolinska Institutet, Northwell Health, Stanford University, University of Kentucky, University of Limerick, University of Pittsburgh, University of Wisconsin, University of Texas Health Sciences Center; and participation on a Data Safety Monitoring Board for National Institutes of Health/National Institute on Drug Abuse. Anne Sales is a co‐investigator on three grants from National Institutes of Health; has received honoraria for a lecture at the University of Kentucky; and is the Chair of the Data and Safety Monitoring Board for four asthma‐related projects for the National Heart, Lung, and Blood Institute. Ted Skolarus reports grants from the National Institutes of Health/National Cancer Institute (R01 CA242559 and R37 CA222885) and royalties from UpToDate. Kristian Stensland reports a grant from the National Institutes of Health/National Cancer Institute (T32 CA180984)."

Evidence found in paper:

"FUNDING INFORMATION National Institutes of Health/National Cancer Institute, Grant/Award Number: F32 CA264874."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025